Inventor · disambiguated record
Robert Hermann
Also filed as: HERMANN ROBERT · HERMANN ROBERT B
6 granted patents·3 pending applications·102 citations·filing 1995–2019
82Inventor score
Files withLILLY CO ELI3JANSSEN PHARMACEUTICA NV1LOCHER MATHIAS1SZELENYI ISTVAN1VALEANT PHARMACEUTICALS NORTH1
Top patents by PatentIndex Score
9 records- 0175US5578634A1H-indole-3-acetic acid hydrazide sPLA2 inhibitorsLILLY CO ELI·Filed 1995·Granted Nov 26, 1996·41 cites·10 claims
- 0274US5684034A1H-indole-3-acetamide sPLA2 inhibitorsLILLY CO ELI·Filed 1995·Granted Nov 4, 1997·41 cites·18 claims
- 0367US6545039B1Facilitated administration of α-lipoic acid or derivatives thereofVIATRIS GMBH·Filed 2000·Granted Apr 8, 2003·8 cites·12 claims
- 0466US6252084B11H-indole-3-acetamide sPLA2 inhibitorsLILLY CO ELI·Filed 1997·Granted Jun 26, 2001·12 cites·2 claims
- 0555US8557851B2Combinations of flupirtine and sodium channel inhibiting substances for treating painsSZELENYI ISTVAN·Filed 2009·Granted Oct 15, 2013·0 cites·9 claims
- 0652US7799832B2Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating painsVALEANT PHARMACEUTICALS NORTH·Filed 2003·Granted Sep 21, 2010·0 cites·11 claims
- 0748US2022315633A1Gdf15 analogs and methods for use in decreasing body weight and/or reducing food intakeJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 0843US2010323987A1Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating painsVALEANT PHARMACEUTICALS NORTH AMERICA·Filed 2010·Application pending·0 cites
- 0930US2005288265A1Novel combination of glucocorticoids and pde-4 inhibitors for treating respiratory diseases, allegic diseases, asthma and copdLOCHER MATHIAS·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert Hermann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →